CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 22 filers reported holding CNS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | – | 10,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 534,148 | $951,000 | 0.36% |
| CVI Holdings, LLC | 415,652 | $740,000 | 0.14% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 61,307 | $109,000 | 0.01% |
| Warberg Asset Management LLC | 14,000 | $25,000 | 0.01% |
| Alpha Cubed Investments, LLC | 10,000 | $18,000 | 0.00% |
| Integrated Advisors Network LLC | 10,700 | $19,000 | 0.00% |
| Core Wealth Advisors, Inc. | 550 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 5,000 | $9,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 41 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |